US2017232145A1PendingUtilityA1
Composite Bone Implants
Est. expirySep 4, 2032(~6.1 yrs left)· nominal 20-yr term from priority
A61L 27/3683A61L 27/3821A61L 2430/40A61L 2430/02A61L 27/3691A61L 2430/24A61L 27/3608A61F 2210/0085A61L 27/365A61L 27/3687A61F 2/28A61F 2/3872A61L 27/386A61L 27/3654
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides natural multi-composite bone implants such as bone-connective tissue-bone and osteochondral implants for the replacement and/or repair of, for example and in particular a damaged or defective bone-meniscus-bone joint or a bone-patella tendon-bone joint or osteochondral lesions, methods of preparing the composites and uses thereof. The invention also provides natural or native composite bone-connective tissue-bone and osteochondral matrices or scaffolds that are substantially decellularised for subsequent transplantation/implantation.
Claims
exact text as granted — not AI-modified1 .- 31 . (canceled)
32 . A method of preparing a decellularised multi-composite donor bone tissue matrix for subsequent implantation into a host comprising the steps of:
(i) freezing and thawing the composite tissue matrix; (ii) subjecting bone blocks to a fluid jet; (iii) ultrasonicating the composite tissue matrix (iv) in the instance of the multi-composite tissue matrix comprises a bone-connective tissue-bone structure, teasing apart fascicles at an enthesis region; (v) incubating the composite tissue matrix in a hypotonic solution; (vi) incubating the composite tissue matrix in a hypotonic solution comprising an anionic detergent; (vii) subjecting the composite tissue matrix to hypotonic or isotonic washes; (viii) incubating the tissue in a solution comprising at least one nuclease enzyme; (ix) washing the composite tissue matrix; and (x) further washing of the composite tissue matrix.
33 . The method of claim 32 , wherein the temperature of the freezing steps is between −10 to −85° C.
34 . The method according to claim 32 , wherein the fluid of the fluid jet is pressurised water or phosphate buffered saline (PBS).
35 . The method according to claim 34 , wherein between 250-600 ml of fluid is used to water pile each bone block.
36 . The method according to claim 32 , wherein the ultrasonic energy is applied to a solution in which the multi-composite donor bone tissue matrix is immersed.
37 . The method according to claim 32 , wherein step (v) comprises firstly incubating the composite tissue matrix in a hypotonic solution under freeze/thaw conditions and subsequently a wash in hypotonic buffer under non freeze/thaw conditions.
38 . The method according to claim 32 , further including a storage step the step comprising storing the decellularised composite donor bone-connective tissue-bone tissue matrix at between − 10 to − 85° C.
39 . The method according to claim 32 , further including the step of incubating the composite tissue matrix with an oxidising agent prior to a final wash.
40 . A natural decellularised multi-composite bone transplant product produced by the method of claim 32 .
41 . A method of treatment of an individual requiring knee repair or replacement surgery comprising the steps of preparing a decellularised natural donor bone-medial meniscal-bone transplant product according to the method of claim 32 and replacing the defective or damaged knee joint with the decellularised natural bone-medial meniscus-bone transplant product.
42 . A method of treatment of an individual requiring patella tendon knee repair or replacement surgery comprising the steps of preparing a decellularised natural donor bone-patella tendon-bone transplant product according to the method of claim 32 and replacing the defective or damaged area with the decellularised natural bone-patella tendon-bone transplant product.
43 . A method of treatment of an individual requiring osteochondral repair or replacement surgery comprising the steps of preparing a decellularised natural donor osteochondral transplant product according to the method of claim 32 and replacing the defective or damaged area with the decellularised natural osteochondral transplant product.Join the waitlist — get patent alerts
Track US2017232145A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.